Arizona State Retirement System Rigel Pharmaceuticals Inc Transaction History

Arizona State Retirement System

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$1.1 - $12.2 $453 - $5,026	412 Added 0.89%	46,755 $55,000
Q2 2022 Jul 28, 2022	BUY	$0.67 - $3.19 $78 - $373	117 Added 0.25%	46,343 $52,000
Q1 2022 May 04, 2022	BUY	$2.22 - $3.45 $537 - $834	242 Added 0.53%	46,226 $138,000
Q4 2021 Feb 04, 2022	SELL	$2.36 - $3.57 $866 - $1,310	-367 Reduced 0.79%	45,984 $122,000
Q3 2021 Nov 12, 2021	BUY	$3.5 - $4.5 $1,459 - $1,876	417 Added 0.91%	46,351 $168,000
Q2 2021 Aug 02, 2021	SELL	$3.09 - $4.54 $10,064 - $14,786	-3,257 Reduced 6.62%	45,934 $199,000
Q1 2021 May 06, 2021	BUY	$3.35 - $4.93 $830 - $1,222	248 Added 0.51%	49,191 $168,000
Q4 2020 Jan 28, 2021	SELL	$2.35 - $3.74 $4,509 - $7,177	-1,919 Reduced 3.77%	48,943 $171,000
Q3 2020 Nov 05, 2020	BUY	$1.78 - $4.13 $22,810 - $52,925	12,815 Added 33.68%	50,862 $122,000
Q2 2020 Aug 04, 2020	SELL	$1.41 - $2.05 $1,835 - $2,669	-1,302 Reduced 3.31%	38,047 $70,000
Q1 2020 May 05, 2020	BUY	$1.27 - $3.0 $49,973 - $118,047	39,349 New	39,349 $61,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.